HEALTHJul 2 · 11:00 UTCBRIDGE MICHIGANChristopher J. Allen

Opinion | Michigan patients deserve real transparency on drug discount program

The article is an opinion piece advocating for transparency in a drug discount program for Michigan patients. Dr. Christopher J. Allen, a pediatric neurologist in Saginaw, is the author.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

Dr. Christopher J. AllenpersonMichiganplaceSaginawplacedrug discount programtopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHJun 10 · 06:48 UTC
FIRST AID: Patents or patients?
HEALTHMay 28 · 13:26 UTC
STAT+: Pharmalittle: We’re reading about a hepatitis B drug, CVS returns Lilly obesity drug to formularies, and more
HEALTHJun 25 · 17:32 UTC
STAT+: Cassidy proposes bill to rein in 340B drug discount program
HEALTHJun 26 · 13:17 UTC
STAT+: Pharmalittle: We’re reading about a bill to overhaul the 340B program, a new FDA commissioner candidate, and more
HEALTHJun 28 · 14:00 UTC
Dr. Oz’s GLP-1 Bridge could work, but it isn’t a model for price controls
HEALTHJun 23 · 12:45 UTC
HHS has sent drug for Ebola clinical trial